News
Originally from South America, the charismatic tegu made its way to the United States via the pet trade of the 1990s. But a recent discovery shows these reptiles are no strangers to the region -- ...
Engineers have taught a simple submarine robot to take advantage of turbulent forces to propel itself through water.
Current methods of capturing and releasing carbon are expensive and so energy-intensive they often require, counterproductively, the use of fossil fuels. Taking inspiration from plants, researchers ...
Lowering the legal tackle height in women's rugby is proving effective in reducing head contacts between players, a new study suggests. Changes to the tackle height law in women's community rugby in ...
Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.
Scientists turned their sophisticated analytical capabilities for testing athlete samples for performance-enhancing drugs to research examining the U.S. meat supply. The study was designed to ...
A team has developed Boccia XR, a rehabilitation program using extended reality technology that can be introduced even in environments with limited space.
A team of researchers has identified distinct mother-offspring attachment types in wild chimpanzees (Pan troglodytes verus). Drawing parallels with human psychology, the study provides compelling ...
El Nino-Southern Oscillation (ENSO) is known to have a significant impact on climate across the Pacific, including Hawai'i, and adjacent continents. However, atmospheric scientists have now revealed ...
Massive ripples in the very fabric of space and time wash over Earth constantly, although you'd never notice. An astrophysicist is trying a new search for these gravitational waves.
A new study finds that an easily measurable brain wave shift of phase may be a universal marker of unconsciousness under general anesthesia.
In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results